Home » Healthcare » Pharmaceuticals » Markt für die Behandlung der Amyotrophen Lateralsklerose (ALS)

Markt für die Behandlung der Amyotrophen Lateralsklerose (ALS)

Markt für die Behandlung der Amyotrophen Lateralsklerose (ALS) nach Typ (Sporadische ALS, Familiäre ALS); Nach Medikament (Riluzol, Edaravon, Andere); Nach Vertriebskanal (Krankenhausapotheken, Einzelhandelsapotheken, Andere) – Wachstum, Anteil, Chancen & Wettbewerbsanalyse, 2024 – 2032

Zusammenfassung
Inhaltsverzeichnis
Kostenloses Muster anfordern

Fordern Sie ein kostenloses Muster an

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Fordern Sie Ihren Musterbericht an und starten Sie Ihre Reise zu fundierten Entscheidungen

Bereitstellung des strategischen Kompasses für Branchenriesen.

Häufig gestellte Frage:

Wie groß ist der Markt für ALS-Behandlungen weltweit im Jahr 2023, und wie groß wird er voraussichtlich bis 2032 sein?

Der Markt wurde im Jahr 2024 auf etwa 657,0 Millionen USD geschätzt und wird voraussichtlich bis 2032 1.019,2 Millionen USD erreichen, mit einer jährlichen Wachstumsrate (CAGR) von 5,66 % von 2025 bis 2032.

Welche Region hält den größten Marktanteil bei der ALS-Behandlung?

Nordamerika dominiert den ALS-Behandlungsmarkt aufgrund seiner fortschrittlichen Gesundheitsinfrastruktur, höherer Diagnosequoten und der starken Präsenz wichtiger Pharmaunternehmen.

Was sind die aktuellen Trends, die die ALS-Behandlungslandschaft beeinflussen?

Zu den aufkommenden Trends gehören die Einführung von Gen- und Stammzelltherapien, die erhöhte Nutzung von Biomarkern und die Integration von KI und digitalen Gesundheitswerkzeugen in die Krankheitsüberwachung.

Wer sind die führenden Akteure im Markt für ALS-Behandlungen?

Wichtige Unternehmen, die auf dem Markt tätig sind, sind Mitsubishi Tanabe Pharma, Amylyx Pharmaceuticals, Cytokinetics, BrainStorm Cell Therapeutics und Biogen Inc.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

North America Over-the-Counter (OTC) Drugs Market

The North America Over-the-Counter (OTC) Drugs Market size was valued at USD 72,391.68 MN in 2021 and reached USD 93,061.46 MN in 2025. It is anticipated to reach USD 155,694.86 MN by 2032, growing at a CAGR of 6.49% during the forecast period.

North America Specialty Pharmaceuticals Market

The North America Specialty Pharmaceuticals Market size was valued at USD 67,838.21 MN in 2021 and reached USD 109,086.83 MN in 2025. It is anticipated to reach USD 260,733.67 MN by 2032, growing at a CAGR of 11.03% during the forecast period.

Europe Prescription Drugs Market

The Europe Prescription Drugs Market size was valued at USD 294,866.12 MN in 2021 and reached USD 365,960.68 MN in 2025. It is anticipated to reach USD 553,623.53 MN by 2032, growing at a CAGR of 5.13% during the forecast period.

Cell Therapy Consumables Market

Cell therapy consumables Market was valued at USD 3439 million in 2024 and is anticipated to reach USD 7533.31 million by 2032, growing at a CAGR of 10.3% during the forecast period.

Africa Orphan Drugs Market

The Africa Orphan Drugs Market size was valued at USD 792.75 MN in 2021 and reached USD 1,258.16 MN in 2025. It is anticipated to reach USD 2,826.51 MN by 2032, growing at a CAGR of 6.30% during the forecast period.

Africa Biosimilars Market

The Africa Biosimilars Market size was valued at USD 126.63 MN in 2021 and reached USD 200.98 MN in 2025. It is anticipated to reach USD 451.50 MN by 2032, growing at a CAGR of 7.80% during the forecast period.

Europe Dermatology Drugs Market

The Europe Dermatology Drugs Market size was valued at USD 8,384.62 MN in 2021 and reached USD 10,909.79 MN in 2025. It is anticipated to reach USD 17,933.36 MN by 2032, growing at a CAGR of 6.18% during the forecast period.

North America Pain Management Drugs Market

The North America Pain Management Drugs Market size was valued at USD 11,968.20 MN in 2021 and reached USD 14,314.26 MN in 2025. It is anticipated to reach USD 18,345.24 MN by 2032, growing at a CAGR of 2.85% during the forecast period.

North America Respiratory Drugs Market

The North America Respiratory Drugs Market size was valued at USD 4,603.33 MN in 2021 and reached USD 5,912.29 MN in 2025. It is anticipated to reach USD 8,990.65 MN by 2032, growing at a CAGR of 5.07% during the forecast period.

North America CNS Drugs Market

The North America CNS Drugs Market size was valued at USD 29,971.81 MN in 2021 and reached USD 39,376.62 MN in 2025. It is anticipated to reach USD 64,694.22 MN by 2032, growing at a CAGR of 6.13% during the forecast period.

Asia Pacific Gastrointestinal Drugs Market

The Asia Pacific Gastrointestinal Drugs Market size was valued at USD 14,076.07 MN in 2021 and reached USD 18,379.23 MN in 2025. It is anticipated to reach USD 27,675.57 MN by 2032, growing at a CAGR of 4.86% during the forecast period.

North America Immunology Drugs Market

The North America Immunology Drugs Market size was valued at USD 23,174.02 MN in 2021 and reached USD 34,194.85 MN in 2025. It is anticipated to reach USD 70,564.69 MN by 2032, growing at a CAGR of 9.11% during the forecast period.

Lizenzoption

Einzelbenutzer

$4999

Mehrbenutzer

$5999

Unternehmen

$7999

Report delivery within 24 to 48 hours

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materialwissenschaftler
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Managementassistent, Bekaert

Vertraut von

Request Sample